Duodenal mucosal resurfacing combined with glucagon-like peptide-1 receptor agonism to discontinue insulin in type 2 diabetes: a feasibility study

Authors:

Abstract
No abstract available
Funding Information
  • Boehringer Ingelheim

This publication has 23 references indexed in Scilit: